Attached files
| file | filename |
|---|---|
| EX-23 - CONSENT OF ERNST & YOUNG LLP - BOSTON SCIENTIFIC CORP | exhibit23_16657.htm |
| EX-99.3 - ITEM 8. FINANCIAL STATEMENTS - BOSTON SCIENTIFIC CORP | exhibit99-3_16657.htm |
| EX-99.2 - ITEM 7. MD&A - BOSTON SCIENTIFIC CORP | exhibit99-2_16657.htm |
| EX-99.1 - ITEM 1. BUSINESS - BOSTON SCIENTIFIC CORP | exhibit99-1_16657.htm |
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of
Report (Date of earliest event reported): December 10, 2009
BOSTON
SCIENTIFIC CORPORATION
(Exact
name of registrant as specified in charter)
|
DELAWARE
|
1-11083 |
04-2695240
|
|
(State
or other jurisdiction incorporation)
|
(Commission file
number)
|
(IRS
employer identification no.)
|
|
One Boston Scientific Place,
Natick, Massachusetts
|
01760-1537
|
|
(Address of
principal executive offices)
|
(Zip
code)
|
Registrant’s
telephone number, including area code: (508) 650-8000
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the fling obligation of the registrant under any of the following
provisions:
o Written
communication pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
ITEM 8.01
|
OTHER
EVENTS
|
On
February 27, 2009, Boston Scientific Corporation (the “Company”) filed its Annual
Report on Form 10-K for the year ended December 31, 2008. Effective
January 1, 2009, the Company reorganized its international structure to
provide more direct sales focus in the marketplace. Accordingly, the Company
revised its reportable segments in its 2009 Quarterly Reports filed on Form 10-Q
to reflect the way it currently manages and views its business. On this Form
8-K, the Company has revised certain sections within its 2008 Form 10-K to give
retroactive effect to the change in reportable segments. All other information
in the 2008 Form 10-K remains unchanged.
The
revisions to the 2008 Form 10-K are as follows:
|
|
1.
|
The
discussion of the Company’s reportable segments on page 13 under the
heading "International Operations" within Item 1 of the Company’s
2008 Form 10-K is revised to reflect the change in the Company’s
reportable segments.
|
|
|
2.
|
The
discussion and presentation of net sales by reportable segment on
page 50 under the heading "Results of Operations" within Item 7 of
the Company’s 2008 Form 10-K is revised to reflect the change in the
Company’s reportable segments.
|
|
|
3.
|
The discussion
of the allocation of goodwill and the roll forward of the Company’s
goodwill balance by reportable segment on pages 107-108 in Note
E, Goodwill and Other
Intangible Assets, to the Company’s consolidated financial
statements contained in Item 8 of its 2008 Form 10-K is revised to reflect
the change in the Company’s reportable
segments.
|
|
|
4.
|
The
discussion and presentation of information by reportable segment on
pages 141-142 in Note P, Segment Reporting, to
the Company’s consolidated financial statements contained in Item 8 of its
2008 Form 10-K is revised to reflect the change
in the Company’s reportable
segments.
|
This
Current Report on Form 8-K does not reflect events or developments that occurred
after February 27, 2009, and does not modify or update the disclosures in
any way other than as required to reflect the effect of the change in the
Company’s reportable segments described above. More current information is
contained in the Company’s Quarterly Reports on Form 10-Q for the periods ended
March 31, June 30, and September 30, 2009 and other filings with the
SEC. The information in this Current Report on Form 8-K should be read in
conjunction with the 2008 Form 10-K, the Forms 10-Q for the periods ended
March 31, June 30, and September 30, 2009 and other documents filed by
the Company with the SEC subsequent to February 27, 2009. Revisions to the
2008 Form 10-K included in this Current Report on Form 8-K as noted above
supersede the corresponding portions of the Company’s 2008 Form 10-K filed on
February 27, 2009.
|
ITEM 9.01
|
FINANCIAL
STATEMENTS AND EXHIBITS
|
|
Exhibit No.
|
Description
|
|
|
23
|
Consent
of Independent Registered Public Accounting Firm, Ernst & Young
LLP
|
|
|
99.1
|
Item
1. Business
|
|
|
99.2
|
Item
7. Management’s Discussion and Analysis of Financial Condition
and Results of Operations
|
|
|
99.3
|
Item
8. Financial Statements and Supplementary Data
|
- 2 -
SIGNATURE
Pursuant to the
requirements of the Securities and Exchange Act of 1934, as amended, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
| BOSTON SCIENTIFIC CORPORATION | |||
|
Date: December
10, 2009
|
By:
|
/s/ Lawrence J. Knopf | |
| Lawrence J. Knopf | |||
| Senior Vice President and Deputy General Counsel | |||
- 3
-
INDEX
TO EXHIBITS
|
Exhibit No.
|
Description
|
|
|
23
|
Consent
of Independent Registered Public Accounting Firm, Ernst & Young
LLP
|
|
|
99.1
|
Item
1. Business
|
|
|
99.2
|
Item
7. Management’s Discussion and Analysis of Financial Condition
and Results of Operations
|
|
|
99.3
|
Item
8. Financial Statements and Supplementary Data
|
- 4
-